Cargando…
Managing Endocrine Disorders in Adults After Hematopoietic Stem Cell Transplantation
Hematopoietic stem cell transplantation (HSCT) has become a potentially curative therapy for an increasing number of malignant and non-malignant conditions. As survival rates continue to improve, the focus of patient care has shifted from managing not only immediate but also long-term complications....
Autores principales: | Matthews, Juliana, Eplin, Dwight, Savani, Bipin, Leon, Barbara Gisella Carranza, Matheny, Leslee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432373/ https://www.ncbi.nlm.nih.gov/pubmed/34595429 http://dx.doi.org/10.2991/chi.d.190917.001 |
Ejemplares similares
-
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Eplin, Dwight D., et al.
Publicado: (2019) -
The Essentials of Drug Interactions in Hematopoietic Stem Cell Transplantation
por: Gatwood, Katie S., et al.
Publicado: (2019) -
SUN-573 Use of PCSK9 Inhibitors Post-Transplant
por: Matthews, Juliana, et al.
Publicado: (2020) -
Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation
por: Yuda, Sayako, et al.
Publicado: (2022) -
Endocrine and Metabolic Disorders after Hematopoietic Cell Transplantation
por: Paviglianiti, Annalisa
Publicado: (2020)